Palvella Therapeutics, Inc. Unrecognized Tax Benefits
Palvella Therapeutics, Inc. (PVLA) had Unrecognized Tax Benefits of $0 as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes
us-gaap:UnrecognizedTaxBenefits · last filed 2026-03-31
- 2025-12-31: Unrecognized Tax Benefits $0.00.
- 2024-12-31: Unrecognized Tax Benefits $0.00.
- 2023-12-31: Unrecognized Tax Benefits $0.00.
- 2022-12-31: Unrecognized Tax Benefits $5.36M.
| Period end | Unrecognized Tax Benefits | Unrecognized Tax Benefits as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-31 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-31 | |
| 2023-12-31 | $0.00 10-K · filed 2024-03-29 | |
| 2022-12-31 | $5.36M 10-K · filed 2024-03-29 | |
| 2021-12-31 | $5.67M 10-K · filed 2023-03-31 | |
| 2020-12-31 | $6.13M 10-K · filed 2022-03-02 | |
| 2019-12-31 | $6.03M 10-K · filed 2021-03-31 | |
| 2018-12-31 | $6.16M 10-K · filed 2020-03-13 | |
| 2017-12-31 | $6.45M 10-K · filed 2019-03-18 | |
| 2016-12-31 | $5.66M 10-K · filed 2018-03-15 | $5.65M 10-K · filed 2017-03-30 |
| 2014-12-31 | $0.00 10-K · filed 2015-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |